Status:
ACTIVE_NOT_RECRUITING
Goals for Adherence with Low-cost Incentives
Lead Sponsor:
RAND
Collaborating Sponsors:
IDinsight
Mildmay Uganda Limited
Conditions:
ART
HIV
Eligibility:
All Genders
15-30 years
Phase:
NA
Brief Summary
GOALS is a three-year randomized control trial (RCT) aimed at testing the effectiveness of three incentive designs to improve the ART adherence of those in need of adherence support. Participants in t...
Detailed Description
Low ART adherence among youth living with HIV threatens positive treatment outcomes. Increasingly incentive interventions have targeted low adherence, yet little is known about how to best structure t...
Eligibility Criteria
Inclusion
- If the participant is between 15 and 30 years of age (inclusive),
- has received ART from Mildmay for at least three months,
- exhibits Wisepill-measured adherence of under 90%,
- and has regular access to a mobile phone (at least five days per week)
Exclusion
- If the participant is not within the age range specified above,
- has not received ART from Mildmay for at least three months,
- cannot use a Wisepill device when taking ART medication,
- cannot follow the consenting procedures
- does not have regular access to a mobile phone (at least five days per week)
- or shows Wisepill-measured adherence of over 90%
Key Trial Info
Start Date :
April 18 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 11 2027
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT05378607
Start Date
April 18 2022
End Date
August 11 2027
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mildmay Uganda
Kampala, Uganda